YOUR TRUSTED PARTNER: DABIGATRAN ETEXILATE MESYLATE IR PELLETS MANUFACTURERS
The path of discovery from an active ingredient to a safe and effective drug is complex and fraught with issues, especially in the world of pharmaceuticals. Jenerx Pharma is a pharmaceutical company passionate about one of the most complex steps in this process: the making of pellets. We are not just pill manufacturers, we are solution providers for more effective drugs, improved safety for patients, and better therapeutic results.
WHAT IS A PHARMACEUTICAL PELLET?
In the pharmaceutical industry, pellets are small spherical particles with diameters from 0.2–2.0 mm, which are free-flowing. They are manufactured by forming small powder particles and excipients into uniform spheres (pellets).
Pellets are “multi-unit” systems, as opposed to a traditional one-piece tablet. This means that hundreds of these tiny spheres can be in one capsule or tablet. This structure has many positive attributes over the traditional formulations, especially in the body.
OUR MISSION: PRECISION AND PERFORMANCE IN DRUG DELIVERY
Our aim is to convert challenging active pharmaceutical ingredients (APIs) into predictable performant oral solid dosage forms. Drug discovery is a contemporary practice that may produce highly active molecules that are impractical to develop into drugs due to their poor solubility, instability or need for a particular release. We specialize in overcoming these challenges.
Our knowledge about pellet technology is applied to the production of various products. Such as:
- Immediate Release
- Sustained Release
- Extended Release
- Modified Release
Our cutting-edge facilities and experienced team enable us to provide you with a complete product development and commercial manufacturing solution. This is why we are considered one of the best dabigatran etexilate mesylate IR pellets manufacturers.
THE CORE ADVANTAGES OF PELLET-BASED FORMULATIONS
Using a pellet product is driven by the significant clinical and manufacturing advantages in using a pellet product. Many times, the use of pellets results in more difficult or unattainable effects with the single-unit dosage forms.
The benefits of doing so include the following:
Strong and reliable Absorption: Small pellets with a consistent passage through the gastrointestinal tract leads to strong and reproducible absorption.
Surface Uniformity: Uniform particle size distribution of our pellets allows for uniform application of functional coatings, reducing batch-to-batch variation and the need to control the amount of API per dose.
Modular Drug release: The pellet core can be used as a modular platform. Through choosing specific polymeric coating, it is possible to obtain a complex release profile of a drug, such as controlled, sustained and targeted release.
Lower Incidence of Dose Dumping: Pellets become dispersed across the gastrointestinal tract, making the chance of an API dose dumping much less than that of a single tablet. Patient safety is of paramount importance.
Minimized Irritation: Uniform distribution of pellets will avoid concentrating the drug in the stomach and irritating the lining of the stomach.
Flexibility in Formulation: Multiple drugs with different release profiles can be combined in the same dosage form of pellets, improving patient compliance.
With the versatility and effectiveness, the demand for dabigatran etexilate mesylate IR pellets manufacturers that can meet tight deadlines and work on high-quality products is on the rise.
OUR CORE CAPABILITIES
Our dedication to quality means that we invest in cutting edge technology. We have dedicated manufacturing facilities that are cGMP compliant. Pellets are manufactured by extrusion-spheronization and/or layering methods, depending on the formulation, using the most suitable and consistent technique for that formulation. This means that the process is as well-controlled as possible and the product quality is maximized.
Our clients receive a full range of services to satisfy their needs, such as:
Pharmaceutical Formulation Development: Our scientists can create robust and scalable formulations to suit the specific characteristics of your API.
Process Scale-Up and Validation: We take your new products from pilot scale to full commercial production, all the way, testing, validating and ensuring consistency along the way.
Stability Batches: Critical step for Regulatory Submission and Product Shelf life of manufacturing.
Analytical Method Development and Testing: We assist you to develop and test product quality through detailed testing including the uniformity of content, and the ability of the product to dissolve.
All the above properties have enhanced our market position as a leading dabigatran etexilate mesylate IR pellets manufacturers.
CHOOSING THE MOST APPROPRIATE DABIGATRAN ETEXILATE MESYLATE IR PELLET MANUFACTURER
Industry Expertise: With a long and rich history of pharmaceutical pellet manufacturing, we are scientifically versed, technologically advanced and have a strong emphasis on quality control to provide you with the highest performing pellet formulations.
We are skilled in:
- Immediate & sustained Controlled & time release pellets
- Development of improved pellet formulation
- Fluid bed coating and pelletizing technology
- Drug delivery systems for personalized medicine
- Pilot scale to commercial scale
- Stringent quality assurance & regulatory compliance
- Technology transfer and process optimisation
Easy Customisation: The need of every pharmaceutical product may vary, and work tirelessly to ensure that we offer highly customized solutions that meets the specific needs of the drug.
Key points:
- Customized pellet formulations
- Immediate, modified and sustained release options
- Custom release and coating properties
- Its strong point is its multiple therapeutic applications
- Formulation development and optimisation
- Making bespoke solutions for customers
FUTURE PROSPECTS
As pharmaceutical science advances, we will continue to innovate, develop new technologies and processes and operate sustainably, while expanding our pellet production capacity. We aim to deliver next-generation pellet solutions and build long-term partnerships with pharmaceutical companies worldwide by conducting research, optimizing processes and implementing global quality standards to meet the evolving demands of healthcare.
Go ahead, join hands with the most sought-after dabigatran etexilate mesylate IR pellets manufacturers and enhance your health outcome.
Other Recommendations: Dabigatran Etexilate Mesylate IR Pellets Suppliers In India